A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
Completed · Phase 2
Conditions studied: Renal Transplant
In brief
The purpose of this study is to learn if conversion to belatacept from cyclosporine or tacrolimus will preserve kidney function in people who have had a kidney transplant. The safety and tolerability of this treatment will also be studied
Key facts
- Study ID
- NCT00402168
- Run by
- Bristol-Myers Squibb
- People needed
- 173
- Starts
- 2007-01-01
- Expected to finish
- 2013-06-01
- Last updated by the study team
- 2017-01-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Hospital — Phoenix, Arizona, United States
- National Institute Of Transplantation — Los Angeles, California, United States
- California Institute Of Renal Research — San Diego, California, United States
- Ucsf — San Francisco, California, United States
- University Of Chicago — Chicago, Illinois, United States
- Pharmacy, First Call Iv — Kenner, Louisiana, United States
- Tulane University Hospital & Clinic — New Orleans, Louisiana, United States
- University Of North Carolina School Of Medicine — Chapel Hill, North Carolina, United States
- Medical College Of Wisconsin — Milwaukee, Wisconsin, United States
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Capital Federal, Buenos Aires, Argentina
- Local Institution — Córdoba, Córdoba Province, Argentina
- Local Institution — Rosario, Santa Fe Province, Argentina
- Local Institution — Santa Fe, Santa Fe Province, Argentina
- Local Institution — Parkville, Victoria, Australia
- Local Institution — Brussels, Belgium
- Local Institution — Edegem, Belgium
- Local Institution — Curitiba, Paraná, Brazil
- Local Institution — Bonsucesso, Rio de Janeiro, Brazil
- Local Institution — Porto Alegre, Rio Grande do Sul, Brazil
- Local Institution — Porto Alegre, Rio Grande do Sul, Brazil
- Local Institution — São Paulo, São Paulo, Brazil
- Local Institution — Edmonton, Alberta, Canada
- Local Institution — Halifax, Nova Scotia, Canada
- Local Institution — Hamilton, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.